Kishan Yalavarthi, MD | |
232 S Woods Mill Rd, Chesterfield, MO 63017-3417 | |
(314) 205-6100 | |
(314) 878-5437 |
Full Name | Kishan Yalavarthi |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 25 Years |
Location | 232 S Woods Mill Rd, Chesterfield, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1841328606 | NPI | - | NPPES |
207309501 | Medicaid | MO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | 2002010077 (Missouri) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
St Lukes Hospital | Chesterfield, MO | Hospital |
Barnes-jewish West County Hospital | Creve coeur, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Diagnostic Imaging Associates Ltd | 9638064942 | 15 |
News Archive
Alpha Pro Tech, Ltd. (NYSE MKT: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three and nine months ended September 30, 2013.
KAIST medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of major focal epilepsy genes accurately and efficiently identified low-level somatic mutations in intractable epilepsy.
Researchers have discovered a strong link between genetic changes known to cause neurodevelopmental disabilities and cerebral palsy.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
› Verified 9 days ago
Entity Name | Diagnostic Imaging Associates Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033142146 PECOS PAC ID: 9638064942 Enrollment ID: O20040217000118 |
News Archive
Alpha Pro Tech, Ltd. (NYSE MKT: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three and nine months ended September 30, 2013.
KAIST medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of major focal epilepsy genes accurately and efficiently identified low-level somatic mutations in intractable epilepsy.
Researchers have discovered a strong link between genetic changes known to cause neurodevelopmental disabilities and cerebral palsy.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kishan Yalavarthi, MD 1715 Deer Tracks Trl, Suite 130, Saint Louis, MO 63131-1839 Ph: (314) 821-5600 | Kishan Yalavarthi, MD 232 S Woods Mill Rd, Chesterfield, MO 63017-3417 Ph: (314) 205-6100 |
News Archive
Alpha Pro Tech, Ltd. (NYSE MKT: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three and nine months ended September 30, 2013.
KAIST medical scientists have developed an advanced method for perfectly detecting low-level somatic mutation in patients with intractable epilepsy. Their study showed that deep sequencing replicates of major focal epilepsy genes accurately and efficiently identified low-level somatic mutations in intractable epilepsy.
Researchers have discovered a strong link between genetic changes known to cause neurodevelopmental disabilities and cerebral palsy.
Aurinia Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused on the global immunology market, today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution (VOS) for the treatment of dry eye syndrome (DES).
› Verified 9 days ago
Dr. James Z. Chen, MD Radiology Medicare: Medicare Enrolled Practice Location: 14014 Camberra Ct, Chen's Radiation, Chesterfield, MO 63017 Phone: 314-469-6893 | |
Peter Holtz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Charles Garvin, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Jennifer Lee Demertzis, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-434-1500 Fax: 314-548-4748 | |
Dr. Robert Kanterman, M.D. Radiology Medicare: Medicare Enrolled Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Dr. Naris Rujanavech, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 232 S Woods Mill Rd, Chesterfield, MO 63017 Phone: 314-205-6100 Fax: 314-878-5437 | |
Michael J Stadnyk, M. D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 36 Chesterfield Lake Road, Chesterfield, MO 63005 Phone: 573-334-6071 Fax: 573-334-4739 |